Literature DB >> 9375589

Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study.

R C Wolfs1, D E Grobbee, A Hofman, P T de Jong.   

Abstract

PURPOSE: To report the prevalence of narrow anterior chamber angles on slit-lamp examination and the incidence of acute angle-closure glaucoma (AACG) after diagnostic mydriasis in nonselected white subjects aged 55 years and over.
METHODS: Of all subjects in the population-based Rotterdam Study (n = 7983), 6760 participated in the ophthalmologic examination and received both tropicamide 0.5% and phenylephrine 5% eye drops for diagnostic mydriasis. No exclusion criteria (e.g., level of intraocular pressure, presence of narrow anterior chamber angles, history of or treatment for glaucoma) were used. After the ophthalmologic examination, all participants received thymoxamine 0.5% drops in both eyes and were warned about the symptoms of AACG.
RESULTS: The prevalence of narrow angles was 2.2% and was twice as high in women. In two subjects (0.03%), an attack of AACG developed in one eye after diagnostic mydriasis. After medical therapy, peripheral iridotomies were made with a Nd:YAG laser, and both eyes healed without loss of visual acuity or visual field.
CONCLUSIONS: In nonselected white subjects of 55 years of age or older, the 2% prevalence of narrow anterior chamber angles is similar to that in a mixed black and white population in the United States. According to our protocol, 3 in 10,000 subjects are likely to develop AACG after diagnostic mydriasis followed by miotic drops.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375589

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

1.  Ophthaproblem. Acute angle-closure glaucoma.

Authors:  S Sharma; J Cheung
Journal:  Can Fam Physician       Date:  2000-02       Impact factor: 3.275

2.  Detection of gonioscopically occludable angles and primary angle closure glaucoma by estimation of limbal chamber depth in Asians: modified grading scheme.

Authors:  P J Foster; J G Devereux; P H Alsbirk; P S Lee; D Uranchimeg; D Machin; G J Johnson; J Baasanhu
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 3.  Non-steroidal drug-induced glaucoma.

Authors:  M R Razeghinejad; M J Pro; L J Katz
Journal:  Eye (Lond)       Date:  2011-06-03       Impact factor: 3.775

4.  Fundoscopy: to dilate or not to dilate?

Authors:  Gerald Liew; Paul Mitchell; Jie Jin Wang; Tien Yin Wong
Journal:  BMJ       Date:  2006-01-07

5.  Direct ophthalmoscopic examination of the eyes: does a mydriatic agent help with diagnosis?

Authors:  A M Carlsson; M W ten Hove; F Stockl
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

6.  IMPORTANCE OF DEMOGRAPHIC RISK FACTORS FOR PRIMARY ANGLE CLOSURE.

Authors:  Alina Mihaela Neacsu
Journal:  Rom J Ophthalmol       Date:  2015 Apr-Jun

7.  Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation.

Authors:  Jacob Szpernal; Joseph Carroll; Ryan Spellecy; Jane A Bachman Groth
Journal:  J Empir Res Hum Res Ethics       Date:  2020-11-02       Impact factor: 1.742

8.  The papilla as screening parameter for early diagnosis of glaucoma.

Authors:  Georg Michelson; Simone Wärntges; Joachim Hornegger; Berthold Lausen
Journal:  Dtsch Arztebl Int       Date:  2008-08-25       Impact factor: 5.594

9.  The East London glaucoma prediction score: web-based validation of glaucoma risk screening tool.

Authors:  Cook Stephen; Longo-Mbenza Benjamin
Journal:  Int J Ophthalmol       Date:  2013-02-18       Impact factor: 1.779

10.  Angle closure glaucoma in the Northern Ireland Diabetic Retinopathy Screening Programme.

Authors:  M A Lagan; M K O'Gallagher; S E Johnston; P M Hart
Journal:  Eye (Lond)       Date:  2016-05-27       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.